IMVT
Immunovant Inc Earnings
$15.27
Earnings Summary
Revenue | $0Mn |
Net Profits | $-120.61Mn |
Net Profit Margins | -Inf% |
Immunovant Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2025. On a quarterly growth basis, Immunovant Inc has generated -100% fall in its revenue since last 3-months.
Immunovant Inc’s net profit fell -38.4% since last year same period to $-120.61Mn in the Q2 2025. On a quarterly growth basis, Immunovant Inc has generated -13.31% fall in its net profits since last 3-months.
Immunovant Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2025. On a quarterly growth basis, Immunovant Inc has generated -Inf% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.71 |
EPS Estimate Current Year | -0.71 |
Immunovant Inc’s earning per share (EPS) estimates for the current quarter stand at -0.71 - a -1.86% fall from last quarter’s estimates.
Immunovant Inc’s earning per share (EPS) estimates for the current year stand at -0.71.
Key Ratios
Earning Per Share (EPS) | 0 |
Immunovant Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Immunovant Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-11 | -0.7 | -0.71 | -1.43% |
2025-10-31 | -0.71 | 0 | 100% |
2025-05-29 | -0.71 | -0.64 | 10.11% |
